[EN] Pharmaceutical businesses need to comprehensively review data policies

In the pharmaceutical sector, customer data extends beyond transactional information to include health data, which is classified as sensitive personal data under the Law on Personal Data Protection 2025 and Decree 356. However, many enterprises have yet to properly classify and manage the sensitivity of such data, resulting in significant legal risks. This podcast analyzes key gaps in current data protection policies, including the failure to distinguish health data, the lack of effective mechanisms for exercising data subject rights, and the challenges in balancing data retention obligations with the right to erasure, thereby highlighting the need for a comprehensive review to ensure compliance and strengthen customer trust._____HM&P Law FirmAddress: 7th Floor, ITAXA Building, 126 Nguyen Thi Minh Khai, Xuan Hoa Ward, HCMCPhone: +84 28 73080839Email: [email protected]: https://hmplaw.vn/